A daily carbohydrate intake of 50 to 55 percent of calories aligns with the lowest mortality risk when evaluating long-term health outcomes.
Popular nutrition advice often treats the carbohydrate ratio as a master control switch for human longevity. Advocates on one side argue that restricting carbohydrates is essential to suppress insulin and prevent chronic disease. Proponents on the other side claim that high-carbohydrate, plant-based diets represent the only validated path to long life. Both perspectives share an assumption: that the proportion of daily calories coming from carbohydrate is the primary variable governing long-term health.
Large-scale nutritional epidemiology and controlled metabolic trials tell a much more nuanced story. The relationship between carbohydrate consumption and lifespan is rarely linear. Furthermore, focusing entirely on macronutrient ratios obscures the biological factors that dictate health outcomes. Food matrix quality, dietary fiber density, micronutrient content, and the specific foods chosen to replace carbohydrates play decisive roles.
To evaluate what the science actually supports, we must examine observational cohort data, randomized trials, and physiological mechanisms side by side. Understanding the distinction between carbohydrate quantity and carbohydrate quality provides a realistic framework for nutritional planning. Looking past simplistic macro targets allows us to inspect the evidence on human aging with objective rigor.
The relationship between total carbohydrate intake and all-cause mortality has been evaluated in several large prospective cohort investigations. The most widely cited analysis comes from the Atherosclerosis Risk in Communities study, known as ARIC. This investigation followed 15,428 adults aged 45 to 64 years at recruitment over a median follow-up period of 25 years. Across this observation window, researchers documented 6,283 deaths while monitoring self-reported dietary patterns.
The ARIC findings demonstrated a distinct U-shaped association between the percentage of energy derived from carbohydrates and overall mortality risk. Both low carbohydrate intake, defined as less than 40 percent of total energy, and high carbohydrate intake, defined as greater than 70 percent of total energy, were linked to higher risk of death compared to moderate consumption. The lowest mortality risk was observed among participants consuming between 50 and 55 percent of their daily calories from carbohydrates.
To test whether these findings held true across broader demographics, the study authors conducted a meta-analysis combining ARIC with seven other prospective cohorts. This pooled dataset included 432,179 participants and 40,181 recorded deaths across North American, European, and Asian populations. The pooled analysis confirmed the U-shaped pattern. Participants consuming less than 40 percent of energy from carbohydrates experienced a 20 percent higher mortality hazard ratio compared to the moderate group. Those consuming more than 70 percent of energy from carbohydrates experienced a 23 percent higher mortality hazard ratio.
The investigators also modeled projected life expectancy from age 50 based on survival curves across these intake categories. A 50-year-old participant consuming less than 30 percent of energy from carbohydrate had an estimated remaining life expectancy of 29.1 years. In contrast, an individual consuming 50 to 55 percent of energy from carbohydrate had an estimated remaining life expectancy of 33.1 years. For those consuming more than 65 percent of energy from carbohydrates, the projected remaining lifespan was 32.0 years. These projected differences illustrate population-level statistical associations rather than individualized guarantees.
It is critical to classify the evidence stage properly. These findings are derived entirely from observational prospective cohort studies. Observational analyses can track thousands of people over decades, but they cannot establish direct biological causation. Dietary intake in ARIC was assessed via self-reported food frequency questionnaires at baseline and updated once during follow-up. Self-reported questionnaires carry inherent measurement errors, and dietary habits often shift over 25 years.
Furthermore, observational data can never completely eliminate residual confounding from unmeasured lifestyle variables. Factors such as physical activity, socioeconomic status, baseline health status, and overall food quality can influence both diet selection and survival. While the U-shaped curve challenges the claim that severe carbohydrate restriction universally optimizes lifespan, it does not prove that eating 50 to 55 percent carbohydrate causes an individual to live longer.
Classifying carbohydrates solely by their gross energy percentage ignores basic nutritional physiology. From a biological standpoint, 50 grams of carbohydrate from intact lentils behaves very differently than 50 grams of carbohydrate from refined flour or high-fructose corn syrup. Evaluating the evidence around longevity nutrition and supplements requires distinguishing between crude macronutrient mass and carbohydrate quality.
Carbohydrate quality is determined by the physical food matrix, fiber content, micronutrient density, and the degree of industrial processing. Intact carbohydrate sources contain plant cell walls that slow down enzymatic digestion in the upper gastrointestinal tract. This delayed breakdown blunts postprandial glucose spikes and delivers complex polysaccharides to the large intestine. In contrast, ultra-processed carbohydrates are rapidly absorbed, driving sharper glycemic excursions and providing little substrate for colonic fermentation.
A comprehensive systematic review and meta-analysis published in The Lancet evaluated the relationship between carbohydrate quality and noncommunicable disease outcomes. The authors analyzed 185 prospective cohort studies and 58 clinical trials to determine how fiber and whole grain intake affected human health. The findings revealed a consistent, dose-dependent decrease in all-cause mortality, cardiovascular disease mortality, and type 2 diabetes incidence with higher intakes of dietary fiber and whole grains.
The dose-response analysis indicated that the greatest risk reductions occurred when daily dietary fiber intake reached 25 to 29 grams per day. Observational data suggested that intakes above 30 grams daily provided additional cardiovascular and metabolic protection. Controlled clinical trials included in the review demonstrated that higher fiber consumption significantly reduced body weight, systolic blood pressure, and total serum cholesterol.
Global health authorities have updated their nutritional guidance to reflect these structural findings. The World Health Organization recommends that carbohydrates come primarily from whole grains, vegetables, fruits, and pulses. For adults, the WHO advises consuming at least 400 grams of vegetables and fruits alongside a minimum of 25 grams of naturally occurring dietary fiber each day. The guidance emphasizes that prioritizing whole food structures is far more effective for disease prevention than pursuing an arbitrary macronutrient ratio.
Targeting carbohydrate quality shifts the focus from restriction to nutrient density. Diets rich in minimally processed whole grains, legumes, root vegetables, and intact fruits supply essential polyphenols, vitamins, and minerals. These compounds support cellular maintenance pathways and reduce systemic inflammatory signaling. Restricting carbohydrates without regard to quality often results in the accidental elimination of these protective, fiber-rich plant foods.
When an individual reduces dietary carbohydrate, those displaced calories are invariably replaced by fat, protein, or both. A low-carbohydrate diet is not a single, uniform biological exposure. A dietary pattern that replaces starches with animal meats and dairy products produces very different physiological effects than one replacing starches with plant oils, nuts, and legumes.
The ARIC study addressed this question directly by analyzing the sources of replacement macronutrients in low-carbohydrate eating patterns. In a pooled substitution analysis encompassing 154,344 participants and 30,959 deaths, researchers examined mortality outcomes based on whether carbohydrate was replaced by animal-derived or plant-derived nutrients. The results demonstrated divergent long-term associations based entirely on the replacement source.
When carbohydrates were substituted with animal-derived fat and protein, such as beef, pork, poultry, and cheese, all-cause mortality risk increased significantly. The pooled hazard ratio for this animal-based low-carbohydrate pattern was 1.18. Conversely, when carbohydrates were substituted with plant-derived fat and protein, such as nuts, peanut butter, whole-grain breads, and vegetables, mortality risk decreased. The pooled hazard ratio for the plant-based low-carbohydrate pattern was 0.82.
These findings highlight why broad labels like "low carb" fail to provide actionable nutritional clarity. In many Western cohorts, individuals adopting low-carbohydrate diets historically consumed higher amounts of saturated fatty acids and processed meats while reducing their intake of fruits, vegetables, and dietary fiber. This combination can elevate atherogenic lipoproteins, increase systemic inflammatory markers, and disrupt the colonic microenvironment.
Conversely, individuals who lower carbohydrate intake by adding avocados, nuts, seeds, extra virgin olive oil, and plant proteins maintain high fiber intakes and consume primarily unsaturated fats. This plant-forward composition supports healthy lipid profiles and provides essential antioxidants. The metabolic impact of carbohydrate reduction depends heavily on the specific nutritional packages chosen to replace those calories.
However, several caveats must be applied to these substitution analyses. In the ARIC cohort, relatively few participants naturally followed an exclusively plant-based low-carbohydrate diet. The mathematical substitution models calculate risk statistically rather than observing randomized dietary assignments in real time. While these data show that plant sources are consistently associated with better survival outcomes, they remain observational associations that require cautious interpretation.
Researchers investigating cellular health and metabolic function emphasize that macronutrient balance cannot be assessed in a biochemical vacuum. Replacing refined starch with extra virgin olive oil and walnuts improves endothelial function and insulin sensitivity. Replacing the same starch with high quantities of processed meats can increase exposure to advanced lipoxidation end-products and heterocyclic amines. The replacement food matters just as much as the food being removed.
While observational cohorts provide insights into mortality patterns over decades, randomized controlled trials offer the clearest view of direct causal effects on short-term risk factors. Proponents of carbohydrate restriction often point to rapid initial weight loss as proof of metabolic superiority. Systematic reviews of controlled trials, however, show that these advantages largely equalize over longer durations.
A comprehensive Cochrane systematic review evaluated the effects of low-carbohydrate diets compared to balanced-carbohydrate diets for weight reduction and cardiovascular risk management. The review analyzed 61 randomized controlled trials comprising 6,925 adults with overweight or obesity, including participants with and without type 2 diabetes. The trials directly compared diets restricting carbohydrates to balanced approaches where carbohydrates comprised 45 to 65 percent of total daily energy.
The Cochrane analysis concluded that low-carbohydrate weight-loss diets result in little to no difference in weight change compared to balanced diets over both short-term and long-term follow-up windows. In trials lasting 3 to 8.5 months, the average difference in weight reduction between the two dietary strategies was negligible. In trials tracking participants for one to two years, weight loss outcomes remained essentially identical across groups when total caloric intake and professional support were equivalent.
The review also evaluated key surrogate biomarkers for cardiovascular disease. Across trial durations of up to two years, researchers found probably little to no difference between low-carbohydrate and balanced-carbohydrate diets for diastolic blood pressure, glycated hemoglobin, or low-density lipoprotein cholesterol. While individual trials reported transient improvements in triglycerides and high-density lipoprotein cholesterol on low-carbohydrate regimens, long-term cardiovascular risk profiles remained broadly comparable.
It is important to recognize the methodological boundaries of these clinical trials. Randomized dietary trials excel at measuring short-term surrogate biomarkers like weight, fasting glucose, serum lipids, and blood pressure. However, these trials are rarely maintained long enough to evaluate hard clinical endpoints, such as myocardial infarction incidence, stroke, or total lifespan. A trial lasting 12 months can demonstrate that two diets produce similar weight loss, but it cannot confirm whether one diet extends human longevity over a 40-year period.
Furthermore, adherence to strict dietary protocols universally declines over time in free-living human populations. In many multi-year trials, participants assigned to very low carbohydrate targets gradually increase their carbohydrate consumption toward moderate levels as the months progress. This adherence decay makes it challenging to evaluate whether prolonged, severe carbohydrate restriction provides distinct metabolic benefits beyond simple caloric restriction.
Weight loss improves cardiometabolic health primarily by reducing visceral adiposity, hepatic steatosis, and systemic inflammation. The trial evidence demonstrates that achieving a sustained energy deficit matters far more for weight reduction than the specific macronutrient split. Claiming that a low-carbohydrate diet is universally superior for body composition or metabolic control oversimplifies the trial data.
The application of carbohydrate restriction in clinical medicine represents a distinct question from population-wide longevity guidance. In individuals with established insulin resistance or type 2 diabetes, carbohydrate intake directly drives postprandial glycemic excursions. In this specific clinical context, reducing carbohydrate mass can serve as a targeted therapeutic intervention to improve glycemic control and reduce pharmacological dependence.
A systematic review and meta-analysis published in the BMJ evaluated the efficacy and safety of low-carbohydrate and very low carbohydrate diets for type 2 diabetes management. The review analyzed 23 randomized controlled trials involving 1,357 participants. The primary outcome was diabetes remission, defined as a glycated hemoglobin level below 6.5 percent, either with or without the use of diabetes medications.
The findings showed that at a six-month follow-up, patients adhering to low-carbohydrate diets achieved significantly higher rates of diabetes remission compared to those on control diets. Specifically, 57 percent of participants in the low-carbohydrate groups achieved remission compared to 31 percent in the control groups. The risk difference was 0.32, indicating a clear, measurable clinical benefit in the short term. Patients also experienced greater reductions in triglycerides and body weight alongside reduced medication requirements.
However, the meta-analysis revealed that these therapeutic advantages diminished considerably at 12 months. As dietary adherence waned over time, the differences in glycemic control and remission rates between low-carbohydrate and control diets narrowed. Additionally, some trials reported modest increases in low-density lipoprotein cholesterol among participants following very low carbohydrate ketogenic regimens, raising questions about individual cardiovascular susceptibility.
This clinical evidence must be interpreted within its proper scope. Demonstrating that carbohydrate restriction can induce short-term diabetes remission does not prove that healthy adults should restrict carbohydrates to extend their lifespan. Type 2 diabetes is a state of severe metabolic dysfunction characterized by impaired insulin secretion and peripheral insulin resistance. Interventions designed to manage a pathological condition cannot be casually translated into universal longevity rules for healthy populations.
Physicians evaluating age biomarkers and metabolic diagnostics distinguish between clinical therapies and preventative lifestyle patterns. For an individual with poorly controlled diabetes, reducing carbohydrate intake can rapidly lower glucose toxicity and reduce hyperinsulinemia. Once metabolic flexibility is restored, maintaining diet quality, physical activity, and adequate fiber intake remains essential for lifelong cardiovascular protection.
Carbohydrate restriction should be viewed as one possible clinical tool among several validated options. Caloric restriction, Mediterranean dietary patterns, and plant-rich balanced diets have also demonstrated effectiveness for diabetes management when adherence is sustained. The key clinical task is matching the dietary strategy to the patient's individual metabolic status, food preferences, and long-term sustainability.
Multiple cellular pathways connect dietary intake to the biology of aging. Carbohydrates influence these pathways primarily through endocrine signaling cascades, advanced glycation processes, and microbiome-derived metabolite production. Examining these mechanisms explains why both severe excess and poor food quality can accelerate cellular decline.
When carbohydrates are digested and absorbed as monosaccharides, circulating blood glucose triggers insulin secretion from pancreatic beta cells. Insulin binds to cell surface receptors, activating downstream signaling pathways including the insulin and insulin-like growth factor 1 cascade. In geroscience, the IIS pathway is a well-studied regulator of longevity. High, persistent activation of insulin signaling stimulates mammalian target of rapamycin complex 1, known as mTORC1, while suppressing protective transcription factors such as FOXO.
Downregulation of FOXO transcription factors diminishes cellular autophagy, the process by which cells clear damaged organelles and protein aggregates. Chronic hyperinsulinemia driven by high-glycemic, ultra-processed carbohydrates can keep mTORC1 persistently active, potentially accelerating aspects of cellular senescence. Conversely, periods of lower insulin signaling allow autophagy to proceed, maintaining cellular proteostasis and organelle quality.
A second major mechanism involves the formation of advanced glycation end-products, commonly called AGEs. When circulating glucose levels remain chronically elevated, reducing sugars react non-enzymatically with free amino groups on long-lived proteins, lipids, and nucleic acids. This process, known as the Maillard reaction, creates irreversible cross-links in structural proteins like collagen and elastin.
Accumulated AGEs alter tissue architecture, causing arterial stiffening, renal microvascular damage, and skin aging. Furthermore, AGEs bind to specific cell-surface receptors called RAGE, triggering intracellular signaling cascades that generate reactive oxygen species and activate nuclear factor kappa B. This transcription factor drives the expression of pro-inflammatory cytokines, contributing to low-grade, sterile chronic inflammation known as inflammaging.
A third critical mechanism operates through the gastrointestinal tract and the gut microbiome. Intact plant carbohydrates contain soluble fibers, resistant starches, and non-starch polysaccharides that resist human digestive enzymes. When these complex fibers reach the colon, commensal anaerobic bacteria ferment them into short-chain fatty acids, primarily acetate, propionate, and butyrate.
Short-chain fatty acids act as crucial signaling molecules throughout the body:
In addition to serving as fuel, short-chain fatty acids function as natural histone deacetylase inhibitors. By inhibiting HDACs, butyrate promotes gene expression patterns that suppress inflammatory cytokine production and support regulatory T-cell differentiation. Diets devoid of fermentable carbohydrates deprive the gut microbiome of substrate, leading to thinning of the protective colonic mucus layer and increased systemic inflammation.
These biological mechanisms illustrate why carbohydrate quality matters far more than gross percentages. Diets high in refined carbohydrates promote chronic hyperglycemia, hyperinsulinemia, and accelerated tissue glycation. Diets rich in unrefined, fiber-dense plant foods deliver micronutrients, support microbiome diversity, produce anti-inflammatory short-chain fatty acids, and maintain stable glucose homeostasis without triggering pathological glycation cascades.
Interpreting the scientific literature on carbohydrates and aging requires an objective assessment of methodological limitations. Nutrition research is notoriously complex, and translating statistical correlations into personal lifestyle rules frequently leads to erroneous conclusions.
A primary limitation in the existing human evidence is reliance on observational cohort designs for long-term mortality endpoints. Prospective cohorts like ARIC, the Nurses' Health Study, and the Health Professionals Follow-Up Study provide valuable hypotheses, but they cannot prove direct causality. Observational studies rely heavily on food frequency questionnaires, which require participants to recall and quantify their food intake over prior months or years. These dietary recall tools are vulnerable to recall bias, social desirability bias, and substantial measurement error.
Furthermore, dietary habits are rarely static across a human lifespan. In many long-term cohorts, diet was assessed only at baseline or at widely spaced intervals separated by several years. Modeling a 25-year mortality risk based on a handful of dietary snapshots assumes that individuals maintained the exact same eating patterns for decades. In reality, personal dietary choices change frequently in response to aging, health diagnoses, weight fluctuations, and cultural trends.
Residual confounding remains an ever-present challenge in nutritional epidemiology. In observational studies, individuals who consume moderate-carbohydrate diets rich in whole grains and vegetables often engage in other health-promoting behaviors. They tend to smoke less, exercise more frequently, possess higher educational attainment, and have better access to healthcare. While multivariable statistical adjustments attempt to control for these factors, unmeasured or poorly measured variables can influence the observed survival curves.
Controlled clinical trials, while methodologically robust against confounding, suffer from their own distinct constraints:
Because of these trial limitations, researchers must rely on intermediate surrogate biomarkers to estimate chronic disease risk. Changes in body weight, fasting plasma glucose, glycated hemoglobin, and lipid fractions provide valuable physiological clues, but they are not perfect substitutes for true lifespan or healthspan measurements. A diet that lowers a specific biomarker over six months does not automatically translate into extended survival over five decades.
Finally, human genetic and metabolic diversity introduces significant variability in individual dietary responses. Variations in salivary amylase gene copy number, baseline insulin sensitivity, physical activity levels, and gut microbiome composition influence how an individual metabolizes carbohydrates. An active individual with high insulin sensitivity possesses a different physiological capacity for carbohydrate handling than a sedentary individual with severe metabolic dysfunction. Universal dietary prescriptions fail to account for these biological differences.
Clear communication in longevity science requires establishing strict boundaries around what the current evidence does and does not support. Exaggerated claims regarding dietary ratios often arise from extrapolating preliminary data beyond their valid scientific limits.
First, the research does not show that adopting a specific carbohydrate percentage guarantees a longer life. The 50 to 55 percent carbohydrate intake associated with the lowest mortality in observational cohorts represents a statistical population average. It is not an optimized clinical prescription that can be universally applied to every individual. Treating this observational reference point as a rigid dietary target misinterprets how epidemiological data function.
Second, the evidence does not demonstrate that carbohydrate restriction accelerates biological aging or causes premature death on an individual level. While the ARIC cohort observed higher mortality among individuals reporting low carbohydrate intake, that association was heavily driven by diets high in animal fats and low in plant-based foods. A carefully formulated, nutrient-dense diet that is lower in carbohydrates but rich in vegetables, nuts, seeds, and healthy oils was associated with lower mortality in the same cohort analysis.
Third, short-term improvements in glycemic markers or weight do not prove that a dietary pattern slows human aging. Commercial biological age testing platforms often claim that dietary modifications can rapidly alter cellular aging clocks. While reducing visceral fat and improving insulin sensitivity supports metabolic health, current scientific tools cannot definitively measure changes in maximum human lifespan resulting from short-term macronutrient shifts.
Fourth, preclinical animal research on caloric restriction and macronutrient ratios cannot be directly mapped onto human eating patterns. Rodent studies evaluating ketogenic diets, protein restriction, or high-carbohydrate feeding occur in genetically homogenous animals kept in tightly controlled laboratory environments. Rodents possess vastly different metabolic rates, lipid transport systems, and dietary evolutionary histories compared to humans. Using rodent lifespan data to dictate human carbohydrate intake oversimplifies comparative biology.
Finally, the evidence does not show that any single macronutrient ratio possesses unique life-extending properties independent of total caloric intake and diet quality. Whether an individual consumes a moderate-carbohydrate Mediterranean pattern or a lower-carbohydrate plant-forward diet, total energy balance, nutrient density, and long-term sustainability remain the foundational drivers of cardiometabolic health.
Evaluating the scientific literature requires familiarity with the standard clinical markers and nutritional metrics used across trials and cohort studies. The following parameters serve as key objective indicators of metabolic function and dietary composition.
Glycated hemoglobin measures the percentage of hemoglobin proteins in red blood cells that have bonded with glucose. Because red blood cells circulate for roughly 120 days, HbA1c reflects average blood glucose concentrations over the preceding two to three months. A level below 5.7 percent is considered normal, 5.7 to 6.4 percent indicates prediabetes, and 6.5 percent or higher confirms diabetes. It is a validated surrogate marker for microvascular and macrovascular disease risk.
HOMA-IR is a mathematical formula calculated from fasting plasma glucose and fasting serum insulin levels. It provides a reliable estimate of hepatic and peripheral insulin resistance in clinical and research settings. Higher HOMA-IR values indicate that pancreatic beta cells must secrete larger amounts of insulin to maintain normal glucose levels, signaling underlying metabolic stress.
LDL-C measures the total mass of cholesterol carried inside low-density lipoprotein particles. Apolipoprotein B measures the total number of atherogenic particles in circulation, including LDL, very low-density lipoproteins, and intermediate-density lipoproteins. Sustained elevations in circulating ApoB particles are causally linked to the development of atherosclerotic cardiovascular disease.
Dietary fiber comprises non-digestible plant carbohydrates that pass through the small intestine intact. Soluble fibers dissolve in water to form viscous gels that slow nutrient absorption, while insoluble fibers add bulk to stool and accelerate transit time. Resistant starch resists amylase digestion in the upper gastrointestinal tract, reaching the colon where it undergoes bacterial fermentation into short-chain fatty acids.
Glycemic index ranks carbohydrate-containing foods on a scale from 0 to 100 based on how rapidly they elevate blood glucose compared to pure glucose. Glycemic load incorporates both the glycemic index of a food and the total amount of available carbohydrate per serving. Diets characterized by a high glycemic load induce sharper postprandial glucose and insulin peaks compared to diets with a lower glycemic load.
Advanced glycation end-products are proteins, lipids, or nucleic acids that have become non-enzymatically glycated following exposure to reducing sugars. Circulating and tissue-bound AGEs can be quantified via laboratory assays or non-invasive skin autofluorescence measurements. Elevated tissue AGE accumulation reflects cumulative lifetime exposure to hyperglycemia and oxidative stress.
Translating these scientific findings into daily practice requires moving past rigid macronutrient dogmatism. Rather than obsessing over an exact carbohydrate percentage, individuals should focus on an integrated nutritional model based on four core pillars: quantity, quality, replacement sources, and personal metabolic context.
The most robust finding across nutritional epidemiology and clinical trials is the clear benefit of unrefined carbohydrate sources. Regardless of the total macronutrient ratio, daily carbohydrate choices should emphasize whole, intact foods.
If an individual chooses to reduce carbohydrate intake for weight management or personal preference, the replacement nutrients should be selected deliberately.
Nutritional planning must account for an individual's current health status, baseline insulin sensitivity, and physical activity levels.
The best-designed nutritional pattern provides zero biological benefit if it cannot be sustained over decades. Severe dietary restrictions often trigger poor compliance, weight regain, and social friction. Selecting an eating pattern that aligns with personal cultural preferences, lifestyle demands, and culinary enjoyment is essential for achieving lifelong cardiometabolic health.
Maintaining lifelong cardiometabolic health depends far less on chasing an ideal carbohydrate ratio and far more on consuming nutrient-dense, minimally processed foods that support stable metabolism and cellular integrity over decades.
Stay current with research on aging biology, biomarkers, nutrition, therapeutics, peptides and longevity technology. AgeAmaze reports what the evidence shows, where uncertainty remains and which claims still need stronger data.
Follow AgeAmaze for careful reporting on what longevity science can show today and what still needs stronger evidence.
read the Blog
